ANGELA FRIEND: Open Payments
NPI 1295302602 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 19 payments from 8 companies in 2025. Trend: 2023 $174 · 2024 $305 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $89 |
| ABBVIE INC. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Alkermes, Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Lundbeck LLC | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: INGREZZA, VRAYLAR, ARISTADA, Jornay PM, REXULTI, FANAPT, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
